Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a multi‐center, open‐label, randomized study. Participants will be assigned to A or B groups with a scale of 1:1 , i.e. infuse study drug followed by Xyntha (group A), or the alternate sequence (group B). All participants who completed the study will enter the Prophylactic Therapy Study.
Epistemonikos ID: de22967ad8ebb0a830e213c2cf031b2fcea6c6aa
First added on: May 22, 2024